← TrialMatch
HomeTrials

Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An Evaluation of

Older adults are sorely underrepresented in suicide prevention research, despite the fact that suicide rates are higher in this age group than in any other age group in Sweden and in many countries worldwide. There are extremely few clinical intervention studies that target this age group, with to date no published stu

Condition(s)Suicidal Ideation, Suicide Attempt, Suicide
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryOlder adults are sorely underrepresented in suicide prevention research, despite the fact that suicide rates are higher in this age group than in any other age group in Sweden and in many countries worldwide. There are extremely few clinical intervention studies that target this age group, with to date no published studies in Europe. The overall aim is to develop and test a modified version of the Attempted Suicide Short Intervention Program (ASSIP), which the investigators will adapt specifically for older adults (65+). The original ASSIP was developed in Switzerland where it has shown an 80% decrease in risk of new suicide attempts compared to ordinary treatment. In Sweden, ASSIP is currently being tested for persons aged 18+ . The investigators now propose a randomised controlled trial
Who can participateInclusion Criteria: 1. Age 65 and above at time of index suicide attempt or hospitalisation for serious suicidal plans. 2. A mental health care contact during the active treatment period. 3. Capable of understanding study procedures and providing informed consent. Exclusion Criteria: 1. Clinical diagnosis of dementia or MoCa score less than -2 standard deviations from the normative score for education and age (Borland et al., 2017). Ongoing delirium, or any other condition impeding the comprehension of the study's procedures and implications that hinder the provision of informed consent. 2. Severe ongoing psychosis, severe ongoing substance use disorder, emotionally instable personality syndrome and any other condition that would require longer specialized treatment to reduce future suicid
Ages65 Years
SexAll
Lead sponsorVastra Gotaland Region
LocationsBorĂ¥s, Sweden; Gothenburg, Sweden
Start date2025-10-01
NCT IDNCT06831942
Official listinghttps://clinicaltrials.gov/study/NCT06831942

🔍 Search all trials →